Arbutus Biopharma Corp’s recently made public that its Officer Sofia Michael J. acquired Company’s shares for reported $0.88 million on Mar 31 ’25. In the deal valued at $3.50 per share,250,000 shares were bought.
Then, Sofia Michael J. bought 250,000 shares, generating $820,000 in total proceeds.
Before that, Sofia Michael J. bought 150,000 shares. Arbutus Biopharma Corp shares valued at $480,000 were divested by the Officer at a price of $3.20 per share.
Jefferies upgraded its Arbutus Biopharma Corp [ABUS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late February with a ‘”a Hold”‘ rating. H.C. Wainwright began covering ABUS with “Buy” recommendation on December 17, 2020.
Price Performance Review of ABUS
On Tuesday, Arbutus Biopharma Corp [NASDAQ:ABUS] saw its stock fall -4.16% to $2.88. Over the last five days, the stock has lost -17.24%. Arbutus Biopharma Corp shares have fallen nearly -11.93% since the year began. Nevertheless, the stocks have fallen -7.69% over the past one year. While a 52-week high of $4.72 was reached on 02/25/25, a 52-week low of $2.63 was recorded on 04/08/25. SMA at 50 days reached $3.34, while 200 days put it at $3.59.
Levels Of Support And Resistance For ABUS Stock
The 24-hour chart illustrates a support level at 2.75, which if violated will result in even more drops to 2.62. On the upside, there is a resistance level at 3.10. A further resistance level may holdings at 3.32. The Relative Strength Index (RSI) on the 14-day chart is 31.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.81%. Stochastics %K at 12.47% indicates the stock is a buying.
How much short interest is there in Arbutus Biopharma Corp?
A steep rise in short interest was recorded in Arbutus Biopharma Corp stocks on 2025-03-14, growing by 2.36 million shares to a total of 9.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 7.21 million shares. There was a rise of 24.67%, which implies that there is a positive sentiment for the stock.
